Does BENDAMUSTINE Cause Mantle cell lymphoma? 109 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Mantle cell lymphoma have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 0.6% of all adverse event reports for BENDAMUSTINE.
109
Reports of Mantle cell lymphoma with BENDAMUSTINE
0.6%
of all BENDAMUSTINE reports
33
Deaths
51
Hospitalizations
How Dangerous Is Mantle cell lymphoma From BENDAMUSTINE?
Of the 109 reports, 33 (30.3%) resulted in death, 51 (46.8%) required hospitalization, and 8 (7.3%) were considered life-threatening.
Is Mantle cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Mantle cell lymphoma?
RITUXIMAB (352)
IBRUTINIB (321)
BORTEZOMIB (184)
LENALIDOMIDE (179)
VENETOCLAX (174)
CYCLOPHOSPHAMIDE (120)
CYTARABINE (114)
VINCRISTINE (112)
DOXORUBICIN (108)
PREDNISONE (96)
Which BENDAMUSTINE Alternatives Have Lower Mantle cell lymphoma Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE